Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

Despite limited data, polymyxin B (PB) is increasingly used clinically as the last therapeutic option for multidrug-resistant (MDR) gram-negative bacterial infections. We examined the in vitro pharmacodynamics of PB against four strains of Pseudomonas aeruginosa. Clonal relatedness of the strains wa...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tam, Vincent H., Schilling, Amy N., Vo, Giao, Kabbara, Samer, Kwa, Andrea L., Wiederhold, Nathan P., Lewis, Russell E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2005
Konular:
Experimental Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1195418/
https://ncbi.nlm.nih.gov/pubmed/16127031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.9.3624-3630.2005
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller